Leading Healthcare Giant Fresenius Establishes ESG Advisory Board

(from left to right): Fabian Kienbaum, Fiona Adshead, Michael Moser, Anahita Thoms, Judith Walls

(IN BRIEF) Fresenius, a global healthcare group, has appointed an independent advisory board to focus on sustainability issues. Comprising four experts from various fields, the board will support the development of Fresenius’ sustainability strategy. This move reflects Fresenius’ commitment to environmental, social, and governance (ESG) principles. The board will work closely with Fresenius’ Management Board member responsible for ESG matters to shape the company’s sustainability agenda.

(PRESS RELEASE) BAD HOMBURG, Germany, 21-Feb-2024 — /EuropaWire/ — Fresenius SE & Co. KGaA (ETR: FRE), an industry-leading, therapy-focused healthcare company, has announced the formation of an independent advisory board dedicated to sustainability matters. Comprising four distinguished international experts from academia, industry, and consulting, the board will provide strategic guidance to Fresenius in the continued development of its sustainability initiatives. Tasked with advising Michael Moser, the Management Board member overseeing environmental, social, and governance (ESG) issues, the advisory board represents Fresenius’ commitment to leading by example in corporate responsibility.

“Together with the newly established sustainability advisory board, we are working on a concrete sustainability plan for the next five years. We want to set new priorities within the company and find answers to the most pressing questions of our time. I am very much looking forward to further expanding our expertise in this crucial area and to working together with leading as well as inspiring advisors,” remarked Michael Sen, CEO of Fresenius.

“Together with the newly established sustainability advisory board, we are working on a concrete sustainability plan for the next five years. We want to set new priorities within the company and find answers to the most pressing questions of our time. I am very much looking forward to further expanding our expertise in this crucial area and to working together with leading as well as inspiring advisors,” said Michael Moser.

Working in tandem with the newly established sustainability advisory board, Fresenius aims to craft a comprehensive sustainability roadmap for the next five years. This strategic plan will delineate key priorities and address pressing contemporary challenges, further bolstering the company’s expertise in this critical domain. Michael Moser expressed anticipation for the collaboration, emphasizing the importance of tapping into the insights of esteemed advisors to enhance Fresenius’ sustainability endeavors.

The ESG Advisory Board will play a pivotal role in shaping Fresenius’ sustainability trajectory, leveraging its members’ expertise across various spheres relevant to the company’s sustainability efforts. From healthcare design and climate protection to corporate sustainability principles and future-oriented leadership, the board members bring a wealth of knowledge to the table.

Fresenius has already made significant strides in sustainability, evident in its 22% reduction in CO2 emissions compared to 2020 levels. Aligned with its commitment to environmental stewardship, the company is on course to halve its CO2 emissions by 2030 and achieve climate neutrality by 2040. Additionally, Fresenius recently pledged its support to the World Economic Forum’s Zero Health Gaps initiative, underscoring its dedication to fostering health equity and equal opportunities in healthcare.

The distinguished members of the ESG Advisory Board include:

• Anahita Thoms (Chairwoman): A leading figure in international trade law and sustainability, Anahita Thoms brings extensive experience from her role at Baker McKenzie and affiliations with organizations such as UNICEF Germany and the American Bar Association.
• Fiona Adshead: Former Deputy Chief Medical Officer in the UK Government, Fiona Adshead is a renowned expert on sustainability and health, currently chairing the Sustainable Healthcare Coalition.
• Fabian Kienbaum: With expertise in corporate governance and succession planning, Fabian Kienbaum, managing partner at Kienbaum, specializes in advising family businesses and leadership development.
• Prof. Judith Walls: Judith Walls, Chair of Sustainability Management at the University of St. Gallen, is a respected authority in sustainability research, focusing on the intersection of business and environmental sustainability.

The establishment of the ESG Advisory Board underscores Fresenius’ unwavering commitment to sustainability and its dedication to driving positive change in the healthcare industry and beyond.

This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, the availability of financing and unforeseen impacts of international conflicts.
Fresenius does not undertake any responsibility to update the forward-looking statements in this release.

Media contact:

Leif Heussen
T +49 (0) 6172 608-4030
leif.heussen@fresenius.com

SOURCE: Fresenius SE & Co. KGaA